Evidence map›Paper›PMID 32179587›Full record

Trial reportHeart (British Cardiac Society)2020

Lifestyle modification in older versus younger patients with coronary artery disease.

Patricia Jepma, Harald T Jorstad, Marjolein Snaterse, Gerben Ter Riet, Hans Kragten, Sangeeta Lachman, Madelon Minneboo, S Matthijs Boekholdt, Ron J Peters, Wilma Scholte Op Reimer

Open access · hybridAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Heart (British Cardiac Society), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Exercise-based cardiac rehabilitation for coronary heart disease.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Epidemiology, Pathophysiology, and Management of Coronary Artery Disease in the Elderly.The International journal of angiology : official publication of the International College of Angiology, Inc · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Patricia JepmaDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands p.jepma@amsterdamumc.nl.ORCID 0000-0003-1271-6869
Harald T JorstadDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Marjolein SnaterseAchieve Centre for Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands.
Gerben Ter RietDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Hans KragtenCardiology, Zuyderland Medical Centre, Heerlen, The Netherlands.
Sangeeta LachmanDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Madelon MinnebooDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
S Matthijs BoekholdtDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ron J PetersDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Wilma Scholte Op ReimerAchieve Centre for Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLZuyderland Medisch Centrum · NLAmsterdam University of Applied Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the treatment effect on lifestyle-related risk factors (LRFs) in older (≥65 years) versus younger (<65 years) patients with coronary artery disease (CAD) in The Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists 2 (RESPONSE-2) trial.

methodsThe RESPONSE-2 trial was a community-based lifestyle intervention trial (n=824) comparing nurse-coordinated referral with a comprehensive set of three lifestyle interventions (physical activity, weight reduction and/or smoking cessation) to usual care. In the current analysis, our primary outcome was the proportion of patients with improvement at 12 months follow-up (n=711) in ≥1 LRF stratified by age.

resultsAt baseline, older patients (n=245, mean age 69.2±3.9 years) had more adverse cardiovascular risk profiles and comorbidities than younger patients (n=579, mean age 53.7±6.6 years). There was no significant variation on the treatment effect according to age (p value treatment by age=0.45, OR 1.67, 95% CI 1.22 to 2.31). However, older patients were more likely to achieve ≥5% weight loss (OR old 5.58, 95% CI 2.77 to 11.26 vs OR young 1.57, 95% CI 0.98 to 2.49, p=0.003) and younger patients were more likely to show non-improved LRFs (OR old 0.38, 95% CI 0.22 to 0.67 vs OR young 0.88, 95% CI 0.61 to 1.26, p=0.01).

conclusionDespite more adverse cardiovascular risk profiles and comorbidities among older patients, nurse-coordinated referral to a community-based lifestyle intervention was at least as successful in improving LRFs in older as in younger patients. Higher age alone should not be a reason to withhold lifestyle interventions in patients with CAD.

Indexed as

Ambulatory CareHealthy LifestyleNurse CliniciansRisk Reduction BehaviorSecondary PreventionAdultAgedAged, 80 and overAge FactorsComorbidityCoronary Artery DiseaseDiet, HealthyExerciseFemaleHeart Disease Risk FactorsHumansagedcoronary artery diseasedisease managementsecondary prevention

Identifiers

PMID32179587
PMCPMC7361002
OpenAlexW3011034204

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.